INOVIO Pharmaceuticals will report Q3 2026 results on Nov. 10 after the close. Management will host a 4:30 p.m. ET call and business update, with investors watc

INOVIO Pharmaceuticals will report Q3 2026 results on Nov. 10 after the close. Management will host a 4:30 p.m. ET call and business update, with investors watching for commentary after this year’s FDA accelerated approval for its DNA-based therapy.